(6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide

C53H87F2N3O13 — CID 89192340

IUPAC(6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide
SMILESCC[C@H]1OC(=O)[C@H](C)C(O)[C@H](C)C(O[C@@H]2O[C@H](C)C[C@@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CCCNC(=O)[C@@]2(O)[C@H](C)CC3C4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@@]32C)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C53H87F2N3O13/c1-14-40-51(11,67)43(63)32(7)58(26-27(2)24-50(10,66)44(30(5)41(61)31(6)45(64)70-40)71-46-42(62)38(57(12)13)21-29(4)69-46)19-15-18-56-47(65)53(68)28(3)20-34-35-23-37(54)36-22-33(59)16-17-48(36,8)52(35,55)39(60)25-49(34,53)9/h16-17,22,27-32,34-35,37-44,46,60-63,66-68H,14-15,18-21,23-26H2,1-13H3,(H,56,65)/t27-,28-,29-,30+,31-,32-,34?,35?,37+,38-,39+,40-,41?,42-,43-,44?,46+,48+,49+,50-,51-,52+,53+/m1/s1
InChIKeyJWRBTZXGCWFRMT-USBFVABKSA-N
MW1012.28 g/mol
LogP3.15
Rot. Bonds9

About (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide

(6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide (PubChem CID 89192340) has the molecular formula C53H87F2N3O13 and a molecular weight of 1012.28 g/mol. Its IUPAC name is (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide.

Molecular Properties

Compound Name(6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide
PubChem CID89192340
Molecular FormulaC53H87F2N3O13
Molecular Weight1012.28 g/mol
Exact Mass1011.62
IUPAC Name(6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide
SMILESCC[C@H]1OC(=O)[C@H](C)C(O)[C@H](C)C(O[C@@H]2O[C@H](C)C[C@@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CCCNC(=O)[C@@]2(O)[C@H](C)CC3C4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@@]32C)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C53H87F2N3O13/c1-14-40-51(11,67)43(63)32(7)58(26-27(2)24-50(10,66)44(30(5)41(61)31(6)45(64)70-40)71-46-42(62)38(57(12)13)21-29(4)69-46)19-15-18-56-47(65)53(68)28(3)20-34-35-23-37(54)36-22-33(59)16-17-48(36,8)52(35,55)39(60)25-49(34,53)9/h16-17,22,27-32,34-35,37-44,46,60-63,66-68H,14-15,18-21,23-26H2,1-13H3,(H,56,65)/t27-,28-,29-,30+,31-,32-,34?,35?,37+,38-,39+,40-,41?,42-,43-,44?,46+,48+,49+,50-,51-,52+,53+/m1/s1
InChIKeyJWRBTZXGCWFRMT-USBFVABKSA-N
XLogP3.15
TPSA239.02 Ų
H-Bond Donors8
H-Bond Acceptors15
Rotatable Bonds9
Heavy Atoms71
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001012.28
LogP ≤ 53.15
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide?
The IUPAC name of (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide (CID 89192340) is (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide.
What is the SMILES notation for (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide?
The canonical SMILES for (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide is CC[C@H]1OC(=O)[C@H](C)C(O)[C@H](C)C(O[C@@H]2O[C@H](C)C[C@@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CCCNC(=O)[C@@]2(O)[C@H](C)CC3C4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@@]32C)[C@H](C)[C@@H](O)[C@]1(C)O.
What is the InChIKey of (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide?
The InChIKey is JWRBTZXGCWFRMT-USBFVABKSA-N. The full InChI is InChI=1S/C53H87F2N3O13/c1-14-40-51(11,67)43(63)32(7)58(26-27(2)24-50(10,66)44(30(5)41(61)31(6)45(64)70-40)71-46-42(62)38(57(12)13)21-29(4)69-46)19-15-18-56-47(65)53(68)28(3)20-34-35-23-37(54)36-22-33(59)16-17-48(36,8)52(35,55)39(60)25-49(34,53)9/h16-17,22,27-32,34-35,37-44,46,60-63,66-68H,14-15,18-21,23-26H2,1-13H3,(H,56,65)/t27-,28-,29-,30+,31-,32-,34?,35?,37+,38-,39+,40-,41?,42-,43-,44?,46+,48+,49+,50-,51-,52+,53+/m1/s1.
What are the key properties of (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide?
(6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide has a molecular weight of 1012.28 g/mol, XLogP of 3.15, 9 rotatable bonds, 8 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (6S,9R,10S,11S,13S,16R,17R)-N-[3-[(2R,3S,4R,5R,8R,10R,12S,14R)-11-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxamide is sourced from PubChem (CID 89192340), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).